Boehringer Ingelheim (Canada) Ltd. named as Hamilton-Niagara Top Employer 2019
Burlington, Ontario (Nov. 21, 2018) – Boehringer Ingelheim (Canada) Ltd. has been named as one of the top employers in Hamilton-Niagara for 2019. This special designation recognizes employers in greater Hamilton and the Niagara region that lead their industries in offering exceptional places to work.
“We are honoured to be recognized as one of the Top Employers in Hamilton-Niagara,” said Richard Mole, President and CEO of Boehringer Ingelheim (Canada) Ltd. “Every day, our colleagues help improve the health of Canadian patients and enable them to continue doing the things that matter most to them. This award reflects the value we place on our employees and the work they do.”
Boehringer Ingelheim is one of the world’s leading pharmaceutical companies and is unique in its industry because it is still family owned. Founded over 130 years ago by Albert Boehringer, the company strives each day to live up to the high ethical standards he set.
Boehringer Ingelheim has operated in Canada since 1972 and its Canadian headquarters are located in Burlington. The company employs approximately 600 people across the country, and each of them are driven to find new and better ways of improving the health of humans and animals.
To be selected as a Top Employer, companies are compared to other organizations in their field to determine which offer the most progressive and forward-thinking programs. They are graded on eight criteria: physical workplace, work atmosphere and social, health, financial and family benefits, vacation and time off, employee communications, performance management, training and skills development and community involvement.
The full list of Hamilton-Niagara’s Top Employers for 2019 and the detailed reasons for selection are available on the competition homepage.
About Boehringer Ingelheim (Canada) Ltd.
Boehringer Ingelheim (Canada) Ltd.
Improving the health and quality of life of patients is the goal of Boehringer Ingelheim, a research-driven pharmaceutical company. In doing so, the focus is on diseases for which no satisfactory treatment option exists to date. The company therefore concentrates on developing innovative therapies that can extend patients’ lives. In animal health, Boehringer Ingelheim stands for advanced prevention.
Family-owned since it was established in 1885, Boehringer Ingelheim is one of the top 20 companies in the pharmaceutical industry. Some 50,000 employees create value through innovation daily for the three business areas human pharmaceuticals, animal health and biopharmaceuticals. In 2017, Boehringer Ingelheim achieved net sales of nearly 18.1 billion euros. Research and development expenditure, exceeding three billion euros, corresponded to 17.0 per cent of net sales.
As a family-owned company, Boehringer Ingelheim plans in generations and focuses on long-term success, rather than short-term profit. The company therefore aims at organic growth from its own resources with simultaneous openness to partnerships and strategic alliances in research. In everything it does, Boehringer Ingelheim naturally adopts responsibility towards mankind and the environment.
The Canadian headquarters of Boehringer Ingelheim was established in 1972 in Montreal, Quebec and is now located in Burlington, Ontario. Boehringer Ingelheim employs approximately 600 people across Canada.
More information about Boehringer Ingelheim can be found at www.boehringer-ingelheim.ca or in our annual report: http://annualreport.boehringer-ingelheim.com.